Crews Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.5M Sell
5,620
-33
-0.6% -$38.9K 0.86% 24
2026
Q2
$6.78M Sell
5,653
-170
-3% -$174K 0.89% 23
2026
Q1
$5.36M Sell
5,823
-28
-0.5% -$28.4K 0.78% 25
2025
Q4
$6.29M Sell
5,851
-122
-2% -$117K 0.9% 23
2025
Q3
$4.56M Sell
5,973
-56
-0.9% -$41.7K 0.67% 28
2025
Q2
$4.7M Buy
6,029
+45
+0.8% +$35K 0.74% 26
2025
Q1
$4.94M Sell
5,984
-61
-1% -$50.8K 0.84% 23
2024
Q4
$4.67M Buy
+6,045
New +$5.01M 0.79% 26

Other funds holding LLY

Crews Bank & Trust's LLY Position: Q3 2026 in Review

Crews Bank & Trust reduced its Eli Lilly (LLY) stake by 0.58% in Q3 2026, selling an estimated $38.9K and leaving 5,620 shares worth $6.5M. The position accounts for 0.86% of the portfolio, ranked #24.

Crews Bank & Trust first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. The position peaked at $6.78M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Crews Bank & Trust held 5,620 shares of Eli Lilly worth $6.5M as of Q3 2026.
  • Crews Bank & Trust sold 33 Eli Lilly shares in Q3 2026, an estimated $38.9K.
  • Eli Lilly made up 0.86% of Crews Bank & Trust's portfolio in Q3 2026, its #24 holding.
  • Crews Bank & Trust first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • Crews Bank & Trust's Eli Lilly position peaked at $6.78M in Q2 2026.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Crews Bank & Trust's 13F filing for Q3 2026, filed 16 Nov 2026.